INTERACTION
ID	lncRNA Name	Interaction target	Level of interaction	Type of interaction	Description	PMID	Source
EL1171	RRP1B	PARP1	RNA-Protein	binding	However, it is highly unlikely that the RRP1B-PARP1 interaction is an experimental artifact, since there is loss of binding with the ΔC-term sample.	19710015	LncRNADisease
EL1171	RRP1B	CSDA	RNA-Protein	binding	Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A).	19710015	LncRNADisease
EL1171	RRP1B	H1X	RNA-Protein	binding	Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A).	19710015	LncRNADisease
EL1171	RRP1B	TRIM28	RNA-Protein	binding	Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A).	19710015	LncRNADisease
EL1171	RRP1B	Cisplatin and paclitaxel	N/A	regulation	Cisplatin and paclitaxel have target function on significant lncRNAs in LSCC, which presents novel molecular targets to cure LSCC patients and also leads an orientation for developing new drugs.	25257554